Celvic Isatu Madonna Coomber

Ms. Celvic Isatu Madonna Coomber


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CCCelvic Isatu Madonna Coomber
Celvic Isatu Madonna Coomber
SCSurahit Chewle
Surahit Chewle
CSChristopher Secker
Christopher Secker
KFKonstantin Fackeldey
Konstantin Fackeldey
Marcus WeberMarcus Weber
Marcus Weber
VSVikram Sunkara
Vikram Sunkara
Endogenous opioids, such as Endomorphin-2, are not typically associated with severe constipation, unlike pharmaceutical opioids, which induce opioid-induced constipation (OIC) by activating μ-opioid receptors in the gastrointestinal tract. In this study, we present a mathematical model, which integrates the serotonergic and opioid pathways, simulating the interaction between serotonin and opioid signaling within the enteric nervous system (ENS). The model explores the mechanisms underlying OIC, with a focus on the change in adenylyl cyclase (AC) activity, cAMP accumulation, and the distinct functionalities of Endomorphin-2 compared to commonly used pharmaceutical opioids. We study the effects of Morphine, Fentanyl, and Methadone and contrast them with Endomorphin-2. Our findings reveal that opioids do not perturb the signaling of serotonin, but only the activity of AC, suggesting that serotonin levels have no influence on improving opioid-induced constipation. Furthermore, this study reveals that the primary difference between endogenous and pharmaceutical opioids is their degradation rates. This finding shows that modulating opioid degradation rates significantly improves cAMP recovery. In conclusion, our insights steer towards exploring opioid degrading enzymes, localized to the gut, as a strategy for mitigating OIC.

28 April 2026 in Receptors
Verified
Journal Article
Open access
PDF file
CCCelvic Isatu Madonna Coomber
Celvic Isatu Madonna Coomber
JKJakob Jonas Kresse
Jakob Jonas Kresse
SCSurahit Chewle
Surahit Chewle
Marcus WeberMarcus Weber
Marcus Weber
CSChristof Schuette
Christof Schuette
VSVikram Sunkara
Vikram Sunkara
Background: Endogenous opioids, such as endomorphin-2, are key regulators of the body’s pain pathways and mediate analgesia by engaging the μ-opioid receptor. This class of opioids are distinguished by their transient activation of the μ-opioid receptor, which is attributed to rapid enzymatic degradation. Methods: To understand how degradation of endomorphin-2 by the enzyme DPP IV affects its interaction with the μ-opioid receptor, we analyzed the ligand–receptor conformational dynamics and interaction patterns of molecular dynamics simulations data of morphine, fentanyl and endomorphin-2 and one degradation product Phe-Phe-NH2, using molecular fingerprints and the mathematical framework ISOKANN. Results: Our analyses revealed that both the clinically relevant opioids, morphine and fentanyl, as well as the endogenous opioid endomorphin-2, adopt a set of recurring binding conformations within the μ-opioid receptor binding pocket, maintaining overlapping interaction motifs throughout the simulations. In contrast, Phe-Phe-NH2 failed to maintain a persistent binding mode over the simulated timescale. This instability arises from the dipeptidyl peptidase IV mediated cleavage of endomorphin-2, which generates Phe-Phe-NH2 and removes critical proline and tyrosine residues, thereby leading to the loss of stabilizing hydrophobic contacts with receptor residues Tyr1503,33, Val2385,43 and Val3026,55. Conclusion: By mapping structural interaction motifs essential for stable μ-opioid receptor binding, this study provides mechanistic insights into how endogenous degradation reshapes ligand–receptor interactions.